METABOLIC POWER DUO — RETATRUTIDE 30 MG + CAGRILINTIDE 10 MG
A two-compound research combination featuring Retatrutide, an investigational GLP-1/GIP/glucagon receptor tri-agonist, and Cagrilintide, an investigational long-acting amylin analog. These compounds are studied across complementary metabolic pathways involving appetite and satiety signaling, energy balance, gastric emptying, and body-composition research.
Designed for laboratory research investigating complementary metabolic signaling pathways.
For research use only. Not for human or veterinary use.
Reviews
There are no reviews yet.